GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kolon TissueGene Inc (XKRX:950160) » Definitions » 5-Year Yield-on-Cost %

Kolon TissueGene (XKRX:950160) 5-Year Yield-on-Cost % : 0.00 (As of May. 03, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Kolon TissueGene 5-Year Yield-on-Cost %?

Kolon TissueGene's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for Kolon TissueGene's 5-Year Yield-on-Cost % or its related term are showing as below:



XKRX:950160's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.685
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Kolon TissueGene's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Kolon TissueGene's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kolon TissueGene's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kolon TissueGene's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Kolon TissueGene's 5-Year Yield-on-Cost % falls into.


;
;

Kolon TissueGene 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Kolon TissueGene is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Kolon TissueGene  (XKRX:950160) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Kolon TissueGene 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Kolon TissueGene's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kolon TissueGene Business Description

Traded in Other Exchanges
N/A
Address
9713 Key West Avenue, Suite 300, Rockville, MD, USA, 20850
Kolon TissueGene Inc is a biopharmaceutical company that develops regenerative therapies for the treatment of various orthopedic disorders. It is developing four product candidates, TG-C, TG-B, TG-D and TG-N for regeneration of cartilage, bone, disc and nerve.

Kolon TissueGene Headlines

No Headlines